Correlation Between Ascendis Pharma and Ultragenyx

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ascendis Pharma and Ultragenyx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ascendis Pharma and Ultragenyx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ascendis Pharma AS and Ultragenyx, you can compare the effects of market volatilities on Ascendis Pharma and Ultragenyx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ascendis Pharma with a short position of Ultragenyx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ascendis Pharma and Ultragenyx.

Diversification Opportunities for Ascendis Pharma and Ultragenyx

0.42
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Ascendis and Ultragenyx is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Ascendis Pharma AS and Ultragenyx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ultragenyx and Ascendis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ascendis Pharma AS are associated (or correlated) with Ultragenyx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ultragenyx has no effect on the direction of Ascendis Pharma i.e., Ascendis Pharma and Ultragenyx go up and down completely randomly.

Pair Corralation between Ascendis Pharma and Ultragenyx

Given the investment horizon of 90 days Ascendis Pharma AS is expected to generate 0.87 times more return on investment than Ultragenyx. However, Ascendis Pharma AS is 1.15 times less risky than Ultragenyx. It trades about 0.01 of its potential returns per unit of risk. Ultragenyx is currently generating about -0.32 per unit of risk. If you would invest  12,769  in Ascendis Pharma AS on August 24, 2024 and sell it today you would earn a total of  1.00  from holding Ascendis Pharma AS or generate 0.01% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Ascendis Pharma AS  vs.  Ultragenyx

 Performance 
       Timeline  
Ascendis Pharma AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ascendis Pharma AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
Ultragenyx 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ultragenyx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Ascendis Pharma and Ultragenyx Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ascendis Pharma and Ultragenyx

The main advantage of trading using opposite Ascendis Pharma and Ultragenyx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ascendis Pharma position performs unexpectedly, Ultragenyx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ultragenyx will offset losses from the drop in Ultragenyx's long position.
The idea behind Ascendis Pharma AS and Ultragenyx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments